Gps Wealth Strategies Group, LLC Acurx Pharmaceuticals, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $612 Million
- Q1 2024
A detailed history of Gps Wealth Strategies Group, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 500 shares of ACXP stock, worth $1,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$1,125
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.25MCall Options Held
16.1KPut Options Held
33.8K-
Vanguard Group Inc Valley Forge, PA492KShares$1.11 Million0.0% of portfolio
-
Prospect Financial Services LLC Melville, NY273KShares$613,9120.55% of portfolio
-
Geode Capital Management, LLC Boston, MA116KShares$261,7920.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ57.3KShares$128,8120.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$97,7980.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $26M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...